Table 4.
Model predictors | R | R2 | R2 corrected | Significance of GE(CBL-DMN) | Significance of the other variable | |
---|---|---|---|---|---|---|
CIMS | GE(CBL-DMN), Age | 0.87 | 0.76 | 0.74 | <0.001 | 0.793 |
GE(CBL-DMN), EDSS | 0.87 | 0.76 | 0.74 | <0.001 | 0.851 | |
GE(CBL-DMN), Disease duration | 0.87 | 0.76 | 0.74 | <0.001 | 0.931 | |
GE(CBL-DMN), WM-LL | 0.88 | 0.77 | 0.74 | <0.001 | 0.630 | |
GE(CBL-DMN), WM-FA | 0.88 | 0.78 | 0.75 | <0.001 | 0.326 | |
GE(CBL-DMN), BPF | 0.88 | 0.78 | 0.75 | <0.001 | 0.634 | |
GE(CBL-DMN), NART-predict | 0.87 | 0.76 | 0.74 | <0.001 | 0.804 | |
GE(CBL-DMN), HADS-A | 0.87 | 0.76 | 0.74 | <0.001 | 0.847 | |
GE(CBL-DMN), HADS-D | 0.88 | 0.78 | 0.75 | <0.001 | 0.296 | |
CPMS | GE(CBL-DMN), Age | 0.57 | 0.32 | 0.29 | <0.001 | 0.063 |
GE(CBL-DMN), EDSS | 0.59 | 0.34 | 0.31 | 0.004 | 0.025 | |
GE(CBL-DMN), Disease duration | 0.51 | 0.26 | 0.23 | <0.001 | 0.867 | |
GE(CBL-DMN), WM-LL | 0.52 | 0.27 | 0.23 | 0.004 | 0.944 | |
GE(CBL-DMN), WM-FA | 0.51 | 0.26 | 0.23 | 0.009 | 0.990 | |
GE(CBL-DMN), BPF | 0.61 | 0.37 | 0.35 | 0.087 | 0.008 | |
GE(CBL-DMN), NART-predict | 0.53 | 0.28 | 0.25 | <0.001 | 0.319 | |
GE(CBL-DMN), HADS-A | 0.51 | 0.26 | 0.23 | <0.001 | 0.813 | |
GE(CBL-DMN), HADS-D | 0.54 | 0.29 | 0.26 | <0.001 | 0.192 | |
Symbol digit modalities test is considered as the dependent variable and GE(CBL-DMN) is tested against each other MRI or clinical variable. The second last column reports the p-values associated with GE(CBL-DMN) within each model and the last column reports the p-value associated with each second predictor. GE(CBL-DMN) holds as the only significant predictor against each other variable in CIMS, while in CPMS EDSS and BPF are also significant predictors of SDMT performance.